Luca Incrocci is Professor of Genito-Urinary Radiotherapy at the Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands. He received his MD in 1992 at the University of Pisa, Italy, and then joined the University Hospital Rotterdam to complete residencies in the Departments of Urology and Radiation Oncology.

His current research is focused on Quality of Life of cancer patients and on the development of radiation techniques to improve treatment outcome and to decrease side effects of radiation therapy for genito-urinary malignancies.

He is actively involved in international programs to provide education and improve radiation therapy access in African countries. He has been a member of the UICC’s Global Task Force on Radiotherapy for Cancer Control and an advisor for developing radiotherapy facilities and PhD programs in Ethiopia. He is part of the Win-Win initiative of the Harvard Global Health Catalyst, and he recently launched his foundation (www.LucaIncrocciFoundation.org) to improve cancer care in Ethiopia.

Prof. Incrocci is member of several scientific societies, he is actively involved in teaching and supervising fellows and PhD students and is author of more than 150 peer-reviewed papers, reviews, book chapters.